POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,887 | +34.9% | 211,297 | -0.2% | 0.00% | – |
| Q2 2023 | $372,650 | +148.0% | 211,733 | +334.0% | 0.00% | – |
| Q1 2023 | $150,252 | -41.9% | 48,783 | 0.0% | 0.00% | – |
| Q4 2022 | $258,550 | +47.7% | 48,783 | -1.4% | 0.00% | – |
| Q3 2022 | $175,000 | +288.9% | 49,468 | +181.7% | 0.00% | – |
| Q2 2022 | $45,000 | -90.2% | 17,558 | -82.8% | 0.00% | – |
| Q1 2022 | $457,000 | -35.4% | 102,049 | -1.7% | 0.00% | – |
| Q4 2021 | $707,000 | -4.3% | 103,839 | +2.4% | 0.00% | – |
| Q3 2021 | $739,000 | -11.0% | 101,388 | +22.3% | 0.00% | – |
| Q2 2021 | $830,000 | +37.6% | 82,900 | +31.4% | 0.00% | – |
| Q1 2021 | $603,000 | +86.1% | 63,100 | +113.3% | 0.00% | – |
| Q4 2020 | $324,000 | +57.3% | 29,581 | +27.0% | 0.00% | – |
| Q3 2020 | $206,000 | – | 23,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |